|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/14 | (2006.01) |
| C07K 5/087 | (2006.01) |
| (11) | Number of the document | 2261236 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10179422.0 |
| Date of filing the European patent application | 2005-12-07 | |
| (97) | Date of publication of the European application | 2010-12-15 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-15 |
| (46) | Date of publication of the claims translation | 2015-11-27 |
| (30) | Number | Date | Country code |
| 634366 P | 2004-12-07 | US | |
| 655930 P | 2005-02-23 | US |
| (72) |
Lewis, Evan R., US
Ho, Mark Nguyen, US
Fonseca, Fabiana N., US
|
| (73) |
Onyx Therapeutics, Inc.,
249 East Grand Avenue, South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicijos, skirtos proteosomų inhibavimui |
| Composition for proteasome inhibition |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 20 | 347.00 EUR |